|
|
embryonic camera type eye formation
|
GO:0060900 |
2 |
0.999
|
|
|
|
smooth muscle cell differentiation
|
GO:0051145 |
8 |
0.958
|
|
|
|
protein dna complex disassembly
|
GO:0032986 |
12 |
0.958
|
Human |
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.929
|
|
|
|
nucleosome disassembly
|
GO:0006337 |
12 |
0.927
|
Human |
|
|
protein complex disassembly
|
GO:0043241 |
52 |
0.905
|
Human |
|
|
chromatin disassembly
|
GO:0031498 |
13 |
0.896
|
Human |
|
|
nucleosome organization
|
GO:0034728 |
66 |
0.896
|
Human |
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.842
|
Human |
|
|
atp dependent chromatin remodeling
|
GO:0043044 |
25 |
0.820
|
|
|
|
viral process
|
GO:0016032 |
146 |
0.811
|
|
|
|
sex determination
|
GO:0007530 |
3 |
0.807
|
|
|
|
vascular smooth muscle cell differentiation
|
GO:0035886 |
3 |
0.763
|
|
|
|
nucleosome positioning
|
GO:0016584 |
3 |
0.754
|
|
|
|
viral life cycle
|
GO:0019058 |
132 |
0.727
|
|
|
|
chromatin remodeling at centromere
|
GO:0031055 |
2 |
0.716
|
|
|
|
positive regulation of viral transcription
|
GO:0050434 |
13 |
0.715
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
114 |
0.693
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
60 |
0.689
|
Human |
|
|
negative regulation of neural precursor cell proliferation
|
GO:2000178 |
1 |
0.671
|
|
|
|
positive regulation of cell fate commitment
|
GO:0010455 |
2 |
0.671
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.630
|
|
|
|
embryonic camera type eye morphogenesis
|
GO:0048596 |
2 |
0.623
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.623
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.601
|
Human |
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.599
|
Human |
|
|
hindbrain development
|
GO:0030902 |
3 |
0.596
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
80 |
0.593
|
Human |
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.570
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.565
|
|
|
|
androgen receptor signaling pathway
|
GO:0030521 |
34 |
0.559
|
Human |
|
|
histone h3 acetylation
|
GO:0043966 |
45 |
0.515
|
|
|
|
oligosaccharide metabolic process
|
GO:0009311 |
13 |
0.513
|
|
|
|
positive regulation of viral process
|
GO:0048524 |
37 |
0.503
|
|
|
|
dna recombination
|
GO:0006310 |
77 |
0.500
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.477
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
39 |
0.463
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.461
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.415
|
|
|
|
regulation of viral transcription
|
GO:0046782 |
34 |
0.414
|
|
|
|
viral gene expression
|
GO:0019080 |
35 |
0.409
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.396
|
|
|
|
intracellular estrogen receptor signaling pathway
|
GO:0030520 |
23 |
0.396
|
Human |
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.391
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
9 |
0.373
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.362
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.361
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.361
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
38 |
0.360
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
92 |
0.360
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.356
|
|
|
|
viral transcription
|
GO:0019083 |
35 |
0.352
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.338
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.335
|
Human |
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.333
|
|
|
|
regulation of viral process
|
GO:0050792 |
103 |
0.329
|
|
|
|
cellular response to starvation
|
GO:0009267 |
58 |
0.326
|
|
|
|
cardiac chamber development
|
GO:0003205 |
30 |
0.322
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.315
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.313
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.312
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.305
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.290
|
|
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.287
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.284
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.283
|
|
|
|
definitive erythrocyte differentiation
|
GO:0060318 |
2 |
0.260
|
|
|
|
regulation of neuroblast proliferation
|
GO:1902692 |
3 |
0.257
|
|
|
|
chromatin assembly
|
GO:0031497 |
61 |
0.252
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.249
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.245
|
|
|
|
multi organism metabolic process
|
GO:0044033 |
41 |
0.244
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.241
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.237
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
3 |
0.232
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.226
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.225
|
|
|
|
chromatin remodeling
|
GO:0006338 |
55 |
0.225
|
Human |
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.224
|
|
|
|
base excision repair
|
GO:0006284 |
21 |
0.221
|
|
|
|
strand invasion
|
GO:0042148 |
2 |
0.216
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.212
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.211
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.206
|
Human |
|
|
chemotaxis
|
GO:0006935 |
157 |
0.204
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.202
|
|
|
|
positive regulation of epidermal growth factor receptor signaling pathway
|
GO:0045742 |
11 |
0.199
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.196
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.196
|
|
|
|
modification of morphology or physiology of other organism
|
GO:0035821 |
43 |
0.194
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.193
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
3 |
0.192
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.192
|
|
|
|
pharyngeal system development
|
GO:0060037 |
2 |
0.191
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.187
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.185
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.184
|
|
|
|
tube closure
|
GO:0060606 |
3 |
0.182
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
36 |
0.179
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.178
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.177
|
|
|
|
positive regulation of erbb signaling pathway
|
GO:1901186 |
11 |
0.175
|
|
|
|
interaction with symbiont
|
GO:0051702 |
26 |
0.173
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
4 |
0.172
|
|
|
|
histone acetylation
|
GO:0016573 |
93 |
0.171
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.170
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.170
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.169
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.167
|
|
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.167
|
|
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.167
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.165
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.159
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.159
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.155
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.155
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.147
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.147
|
|
|
|
double strand break repair
|
GO:0006302 |
101 |
0.144
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.144
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.143
|
Human |
|
|
neurogenesis
|
GO:0022008 |
169 |
0.139
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.137
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.132
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.130
|
|
|
|
chromosome segregation
|
GO:0007059 |
114 |
0.130
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.130
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.128
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.126
|
|
|
|
alcohol catabolic process
|
GO:0046164 |
20 |
0.124
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.123
|
|
|
|
muscle organ development
|
GO:0007517 |
56 |
0.119
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.119
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.118
|
|
|
|
steroid metabolic process
|
GO:0008202 |
94 |
0.117
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.117
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.116
|
|
|
|
toxin transport
|
GO:1901998 |
4 |
0.115
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.114
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.114
|
|
|
|
dendrite development
|
GO:0016358 |
24 |
0.113
|
|
|
|
neural retina development
|
GO:0003407 |
8 |
0.111
|
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
32 |
0.111
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.111
|
|
|
|
negative regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033144 |
18 |
0.111
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.110
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
54 |
0.110
|
|
|
|
memory
|
GO:0007613 |
3 |
0.110
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.107
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.107
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.105
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.105
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.104
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.104
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.103
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.102
|
|
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
2 |
0.101
|
|
|
|
single organism carbohydrate catabolic process
|
GO:0044724 |
33 |
0.099
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.098
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.096
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.096
|
|
|
|
modulation of transcription in other organism involved in symbiotic interaction
|
GO:0052312 |
20 |
0.095
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.095
|
|
|
|
positive regulation of chromatin assembly or disassembly
|
GO:0045799 |
2 |
0.095
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.094
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.094
|
|
|
|
visual learning
|
GO:0008542 |
1 |
0.091
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.091
|
|
|
|
modulation by host of symbiont transcription
|
GO:0052472 |
20 |
0.090
|
|
|
|
chromatin mediated maintenance of transcription
|
GO:0048096 |
2 |
0.090
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
44 |
0.090
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.090
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.089
|
|
|
|
modification by host of symbiont morphology or physiology
|
GO:0051851 |
26 |
0.087
|
|
|
|
gonad development
|
GO:0008406 |
34 |
0.086
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.086
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.086
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.086
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.085
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.084
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.083
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.083
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.082
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.082
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
1 |
0.082
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.079
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.079
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
44 |
0.079
|
|
|
|
negative regulation of stem cell proliferation
|
GO:2000647 |
3 |
0.079
|
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
41 |
0.078
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.078
|
|
|
|
atp catabolic process
|
GO:0006200 |
157 |
0.077
|
|
|
|
oligosaccharide catabolic process
|
GO:0009313 |
4 |
0.075
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.075
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.075
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.074
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.074
|
|
|
|
dna conformation change
|
GO:0071103 |
113 |
0.074
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.072
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.072
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.072
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.071
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.071
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.071
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.070
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
4 |
0.069
|
|
|
|
regulation of cell fate commitment
|
GO:0010453 |
7 |
0.069
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.069
|
|
|
|
histone h3 k27 acetylation
|
GO:0043974 |
2 |
0.069
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.069
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.069
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.069
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.068
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.067
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.066
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.066
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.066
|
|
|
|
corticosteroid receptor signaling pathway
|
GO:0031958 |
5 |
0.065
|
Human |
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.065
|
|
|
|
dna replication
|
GO:0006260 |
116 |
0.064
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.063
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.063
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.063
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.062
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
18 |
0.061
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.061
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.060
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.059
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.059
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.058
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.058
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.058
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.058
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.057
|
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
44 |
0.057
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.057
|
|
|
|
regulation of single species biofilm formation
|
GO:1900190 |
2 |
0.056
|
|
|
|
neural tube closure
|
GO:0001843 |
3 |
0.056
|
|
|
|
dendrite morphogenesis
|
GO:0048813 |
14 |
0.056
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
56 |
0.055
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.055
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.055
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.054
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.054
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.054
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
15 |
0.053
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.053
|
|
|
|
gene silencing
|
GO:0016458 |
49 |
0.053
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.053
|
|
|
|
sex differentiation
|
GO:0007548 |
45 |
0.052
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.052
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.051
|
|
|
|
methylation
|
GO:0032259 |
106 |
0.051
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.051
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.050
|
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.050
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.050
|
|
|
|
histone methylation
|
GO:0016571 |
60 |
0.050
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
3 |
0.049
|
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
10 |
0.049
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.049
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
68 |
0.048
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.048
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.048
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.046
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.046
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.046
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.045
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.045
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.044
|
|
|
|
modulation by host of viral transcription
|
GO:0043921 |
20 |
0.044
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.044
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.044
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.043
|
|
|
|
glucocorticoid receptor signaling pathway
|
GO:0042921 |
5 |
0.043
|
Human |
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.043
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.042
|
|
|
|
growth
|
GO:0040007 |
202 |
0.042
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.042
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.042
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.042
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
84 |
0.041
|
|
|
|
single stranded viral rna replication via double stranded dna intermediate
|
GO:0039692 |
9 |
0.041
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.041
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.040
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.040
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.039
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
37 |
0.039
|
|
|
|
sensory perception of pain
|
GO:0019233 |
4 |
0.039
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.039
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.038
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.038
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
19 |
0.037
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.037
|
|
|
|
smad protein complex assembly
|
GO:0007183 |
12 |
0.037
|
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.037
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.036
|
|
|
|
positive regulation of reproductive process
|
GO:2000243 |
9 |
0.036
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.036
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.036
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
84 |
0.035
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.035
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.035
|
|
|
|
methylation dependent chromatin silencing
|
GO:0006346 |
3 |
0.035
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.035
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.034
|
|
|
|
regulation of erbb signaling pathway
|
GO:1901184 |
27 |
0.034
|
|
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
18 |
0.034
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.034
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.033
|
|
|
|
organic hydroxy compound catabolic process
|
GO:1901616 |
22 |
0.033
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.033
|
|
|
|
negative regulation of histone acetylation
|
GO:0035067 |
6 |
0.033
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.033
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.033
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
27 |
0.032
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
3 |
0.032
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.032
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.032
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.032
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
18 |
0.032
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.031
|
|
|
|
cellular carbohydrate catabolic process
|
GO:0044275 |
17 |
0.031
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.031
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.031
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.030
|
|
|
|
sensory organ development
|
GO:0007423 |
52 |
0.030
|
|
|
|
phagocytosis
|
GO:0006909 |
42 |
0.030
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.029
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.029
|
|
|
|
placenta development
|
GO:0001890 |
10 |
0.028
|
|
|
|
nuclear division
|
GO:0000280 |
128 |
0.028
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.028
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.028
|
|
|
|
head development
|
GO:0060322 |
108 |
0.028
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.027
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.027
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.027
|
|
|
|
viral genome replication
|
GO:0019079 |
50 |
0.027
|
|
|
|
chromatin silencing
|
GO:0006342 |
12 |
0.027
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.027
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.027
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.027
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.026
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.026
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.026
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.026
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.026
|
|
|
|
respiratory gaseous exchange
|
GO:0007585 |
3 |
0.025
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.025
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.025
|
|
|
|
regulation of heterochromatin assembly
|
GO:0031445 |
1 |
0.025
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.025
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.025
|
|
|
|
system process
|
GO:0003008 |
349 |
0.025
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.025
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.025
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.024
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.024
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.024
|
|
|
|
retinal ganglion cell axon guidance
|
GO:0031290 |
2 |
0.024
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.024
|
|
|
|
positive regulation of organic acid transport
|
GO:0032892 |
3 |
0.024
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.024
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.023
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.023
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.023
|
|
|
|
camera type eye development
|
GO:0043010 |
25 |
0.023
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.023
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.023
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
48 |
0.023
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.023
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.023
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.023
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.023
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
4 |
0.023
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
101 |
0.023
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.022
|
|
|
|
renal tubule development
|
GO:0061326 |
19 |
0.022
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.022
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.022
|
|
|
|
cardiac right ventricle morphogenesis
|
GO:0003215 |
3 |
0.022
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.022
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.022
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.021
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.021
|
|
|
|
protein acetylation
|
GO:0006473 |
116 |
0.021
|
|
|
|
negative regulation of protein complex assembly
|
GO:0031333 |
43 |
0.021
|
|
|
|
regulation of behavior
|
GO:0050795 |
82 |
0.021
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.021
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.021
|
|
|
|
organelle localization
|
GO:0051640 |
84 |
0.021
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.021
|
|
|
|
dna packaging
|
GO:0006323 |
77 |
0.021
|
|
|
|
heterochromatin assembly
|
GO:0031507 |
6 |
0.021
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.021
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
35 |
0.021
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.021
|
|
|
|
regulation of striated muscle tissue development
|
GO:0016202 |
26 |
0.021
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.020
|
|
|
|
regulation of respiratory gaseous exchange
|
GO:0043576 |
2 |
0.020
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.020
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
43 |
0.020
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.020
|
|
|
|
regulation of dna binding
|
GO:0051101 |
37 |
0.020
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.020
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.020
|
|
|
|
prostate gland development
|
GO:0030850 |
3 |
0.020
|
|
|
|
genetic imprinting
|
GO:0071514 |
1 |
0.020
|
|
|
|
synaptic transmission
|
GO:0007268 |
61 |
0.019
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.019
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
3 |
0.019
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.019
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
90 |
0.019
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.019
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.019
|
|
|
|
epidermal growth factor receptor signaling pathway
|
GO:0007173 |
39 |
0.019
|
|
|
|
myosin filament organization
|
GO:0031033 |
2 |
0.019
|
|
|
|
axon development
|
GO:0061564 |
34 |
0.019
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.019
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.019
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
54 |
0.019
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.019
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.019
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.018
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.018
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.018
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.018
|
|
|
|
negative regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060633 |
3 |
0.018
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.018
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.018
|
|
|
|
eye morphogenesis
|
GO:0048592 |
16 |
0.018
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.018
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.018
|
|
|
|
endosomal transport
|
GO:0016197 |
129 |
0.018
|
|
|
|
negative regulation of protein catabolic process
|
GO:0042177 |
59 |
0.018
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.018
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.018
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.018
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.018
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
17 |
0.018
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
50 |
0.018
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.018
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.018
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.017
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.017
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.017
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
44 |
0.017
|
|
|
|
positive regulation of i kappab kinase nf kappab signaling
|
GO:0043123 |
132 |
0.017
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.017
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.017
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.017
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.017
|
|
|
|
heart formation
|
GO:0060914 |
2 |
0.017
|
|
|
|
positive regulation of gene expression epigenetic
|
GO:0045815 |
7 |
0.017
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.017
|
|
|
|
bone development
|
GO:0060348 |
26 |
0.017
|
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.017
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.017
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.017
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.017
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.017
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.017
|
|
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.017
|
|
|
|
hair cycle
|
GO:0042633 |
28 |
0.016
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.016
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
35 |
0.016
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.016
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.016
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.016
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.016
|
|
|
|
meiosis i
|
GO:0007127 |
4 |
0.016
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
24 |
0.016
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.016
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.016
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.016
|
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
37 |
0.016
|
|
|
|
negative regulation of neurogenesis
|
GO:0050768 |
26 |
0.016
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.016
|
|
|
|
nuclear import
|
GO:0051170 |
106 |
0.016
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.016
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.016
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.016
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.016
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.016
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.016
|
|
|
|
maintenance of cell polarity
|
GO:0030011 |
2 |
0.016
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.015
|
|
